Balter Invenomic Valuation
| BIVSX Fund | USD 18.32 0.08 0.43% |
At this time, the entity appears to be fairly valued. Balter Invenomic shows a prevailing Real Value of $18.1 per share. The current price of the fund is $18.32. We determine the value of Balter Invenomic from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Balter Invenomic's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Balter Invenomic shows a prevailing Real Value of $18.1 per share. The current price of the fund is $18.32. We determine the value of Balter Invenomic from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Balter Invenomic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Balter Mutual Fund. However, Balter Invenomic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.32 | Real 18.1 | Hype 18.32 | Naive 18.19 |
The intrinsic value of Balter Invenomic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Balter Invenomic's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Balter Invenomic helps investors to forecast how Balter mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Balter Invenomic more accurately as focusing exclusively on Balter Invenomic's fundamentals will not take into account other important factors: About Balter Invenomic Valuation
Our relative valuation model uses a comparative analysis of Balter Invenomic. We calculate exposure to Balter Invenomic's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Balter Invenomic's related companies.Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |